本文章的引用
本文章的通讯作者
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
- 本文章浏览次数 (3327)
All Articles published online
|
Feb 21, 2005 (publication date) through Mar 20, 2025
本文章的被引频次
本文章的期刊信息
出版物名称
World Journal of Gastroenterology
ISSN
1007-9327
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Shen LZ, Hua YB, Yu XM, Xu Q, Chen T, Wang JH, Wu WX. Tamoxifen can reverse multidrug resistance of colorectal carcinoma |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v11/i7/1060.htm |
| 编号 | Citing Articles |
| 1 |
Hong Wang, Yong Zhou, Wen Zhuang, Yi-Qiong Yin, Guan-Jian Liu, Tai-Xiang Wu, Xun Yao, Liang Du, Mao-Ling Wei, Xiao-Ting Wu. Glutathione S-Transferase M1 Null Genotype Associated with Gastric Cancer Among Asians. Digestive Diseases and Sciences 2010; 55(7): 1824 doi: 10.1007/s10620-009-0971-5
|
| 2 |
Zodwa Dlamini, Rodney Hull, Andreas M. Kaufmann. Colorectal Cancer Treatment Resistance. 2025; : 3 doi: 10.1016/B978-0-443-33475-7.00009-3
|
| 3 |
M Mimeault, R Hauke, SK Batra. Recent Advances on the Molecular Mechanisms Involved in the Drug Resistance of Cancer Cells and Novel Targeting Therapies. Clinical Pharmacology & Therapeutics 2008; 83(5): 673 doi: 10.1038/sj.clpt.6100296
|
| 4 |
Adam Hermawan, Herwandhani Putri, Naufa Hanif, Nurul Fatimah, Heri Himawan Prasetio. Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1019025
|
| 5 |
J.M. Maher, X. Cheng, Y. Tanaka, G.L. Scheffer, C.D. Klaassen. Hormonal regulation of renal multidrug resistance-associated proteins 3 and 4 (Mrp3 and Mrp4) in mice. Biochemical Pharmacology 2006; 71(10): 1470 doi: 10.1016/j.bcp.2006.02.005
|
| 6 |
Valentina Martineti, Sandra Silvestri, Francesco Tonelli, Maria Luisa Brandi. Control of colon cancer development and progression by selected estrogen receptor modulators. Expert Review of Endocrinology & Metabolism 2008; 3(4): 503 doi: 10.1586/17446651.3.4.503
|
| 7 |
Regino Mercado-Lubo, Yuanwei Zhang, Liang Zhao, Kyle Rossi, Xiang Wu, Yekui Zou, Antonio Castillo, Jack Leonard, Rita Bortell, Dale L. Greiner, Leonard D. Shultz, Gang Han, Beth A. McCormick. A Salmonella nanoparticle mimic overcomes multidrug resistance in tumours. Nature Communications 2016; 7(1) doi: 10.1038/ncomms12225
|
| 8 |
Shu‐Chang Ma, Jia‐Qi Zhang, Tian‐Hua Yan, Ming‐Xing Miao, Ye‐Min Cao, Yong‐Bing Cao, Li‐Chao Zhang, Ling Li. Novel strategies to reverse chemoresistance in colorectal cancer. Cancer Medicine 2023; 12(10): 11073 doi: 10.1002/cam4.5594
|
| 9 |
Murielle Mimeault, Surinder K. Batra. Recent advances in the development of novel anti‐cancer drugs targeting cancer stem/progenitor cells. Drug Development Research 2008; 69(7): 415 doi: 10.1002/ddr.20273
|
| 10 |
Murielle Mimeault, Surinder K. Batra. Stem Cell Biology in Health and Disease. 2009; : 385 doi: 10.1007/978-90-481-3040-5_17
|
| 11 |
Samy A.F. Morad, Jonathan C. Levin, Su-Fern Tan, Todd E. Fox, David J. Feith, Myles C. Cabot. Novel off-target effect of tamoxifen — Inhibition of acid ceramidase activity in cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2013; 1831(12): 1657 doi: 10.1016/j.bbalip.2013.07.016
|
| 12 |
Corinna Henkel, Martin Roderfeld, Ralf Weiskirchen, Marie-Luise Berres, Sonja Hillebrandt, Frank Lammert, Helmut E. Meyer, Kai Stühler, Jürgen Graf, Elke Roeb. Changes of the hepatic proteome in murine models for toxically induced fibrogenesis and sclerosing cholangitis. PROTEOMICS 2006; 6(24): 6538 doi: 10.1002/pmic.200600580
|
| 13 |
Paul A. Foster. Oestrogen and colorectal cancer: mechanisms and controversies. International Journal of Colorectal Disease 2013; 28(6): 737 doi: 10.1007/s00384-012-1628-y
|
| 14 |
Qian Wang, Yu Cheng, Yan Wang, Yibo Fan, Ce Li, Ye Zhang, Yiding Wang, Qian Dong, Yanju Ma, Yue-e Teng, Xiujuan Qu, Yunpeng Liu. Tamoxifen reverses epithelial–mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3457-4
|
| 15 |
S. V. Boichuk, T. V. Ivoilova. The role of ABC-transporters in homeostasis, cancer pathogenesis and therapy. Advances in Molecular Oncology 2024; 11(1): 8 doi: 10.17650/2313-805X-2024-11-1-8-21
|
| 16 |
Demetra Demetriou, Thulo Molefi, Aristotelis Chatziioannou, Zodwa Dlamini. Colorectal Cancer Treatment Resistance. 2025; : 85 doi: 10.1016/B978-0-443-33475-7.00012-3
|
| 17 |
E. A. Bogush, A. B. Ravcheeva, T. A. Bogush, T. N. Zabotina, Z. G. Kadagidze, M. I. Davydov. A new marker of tamoxifen resistance of estrogen receptor-positive breast cancer. Doklady Biochemistry and Biophysics 2007; 413(1): 83 doi: 10.1134/S1607672907020123
|
| 18 |
Alison Y. Ting, Brian K. Petroff. Tamoxifen decreases ovarian follicular loss from experimental toxicant DMBA and chemotherapy agents cyclophosphamide and doxorubicin in the rat. Journal of Assisted Reproduction and Genetics 2010; 27(11): 591 doi: 10.1007/s10815-010-9463-y
|
| 19 |
Samy A.F. Morad, James P. Madigan, Jonathan C. Levin, Noha Abdelmageed, Ramin Karimi, Daniel W. Rosenberg, Mark Kester, Sriram S. Shanmugavelandy, Myles C. Cabot. Tamoxifen magnifies therapeutic impact of ceramide in human colorectal cancer cells independent of p53. Biochemical Pharmacology 2013; 85(8): 1057 doi: 10.1016/j.bcp.2013.01.015
|
| 20 |
Samy A.F. Morad, Myles C. Cabot. Tamoxifen regulation of sphingolipid metabolism—Therapeutic implications. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2015; 1851(9): 1134 doi: 10.1016/j.bbalip.2015.05.001
|
| 21 |
Nermin S. Ahmed, Marek Samec, Alena Liskova, Peter Kubatka, Luciano Saso. Tamoxifen and oxidative stress: an overlooked connection. Discover Oncology 2021; 12(1) doi: 10.1007/s12672-021-00411-y
|
| 22 |
Paul L. Prather, FeAna FrancisDevaraj, Centdrika R. Dates, Aleksandra K. Greer, Stacie M. Bratton, Benjamin M. Ford, Lirit N. Franks, Anna Radominska-Pandya. CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen. Biochemical and Biophysical Research Communications 2013; 441(2): 339 doi: 10.1016/j.bbrc.2013.10.057
|
| 23 |
Zonglei Mao, Jin Zhou, Junwei Luan, Weihua Sheng, Xiaochun Shen, Xiaoqiang Dong. Tamoxifen reduces P-gp-mediated multidrug resistance via inhibiting the PI3K/Akt signaling pathway in ER-negative human gastric cancer cells. Biomedicine & Pharmacotherapy 2014; 68(2): 179 doi: 10.1016/j.biopha.2013.10.003
|